Skip to main content
. Author manuscript; available in PMC: 2009 Oct 8.
Published in final edited form as: Can J Physiol Pharmacol. 2008 Aug;86(8):557–565. doi: 10.1139/Y08-049

Fig. 5.

Fig. 5

DAB staining was decreased in ET-1-treated vessels and reversed by IL-10 treatment. DAB staining of eNOS on cross-sections (8 µm thick) of aortic rings treated for 22 h at 37 °C with (A) vehicle, (B) ET-1 (100 nmol/L), (C) IL-10 (300 ng/mL), or (D) ET-1 and IL-10. eNOS staining is shown by the arrows.